TITLE: THE KNOWLEDGE, ATTITUDES, PERSONAL HEALTH CAREAND PATIENT CARE PRACTICES OF THE UNIVERSITY OFMEDICINE AND DENTISTRY OF NEW JERSEY FACULTY MEMBERSREGARDING WEIGHT MANAGEMENT

AUTHOR(S): D. Castellano, MS, RD, R. Touger-Decker, PhD, RD, FADA,University of Medicine and Dentistry of NJ; P. Matheson, PhD, L. Byham-Gray, PhD, RD, University of Medicine and Dentistry of NJ; J. O’SullivanMaillet, PhD, RD, FADA; University of Medicine and Dentistry of NJ

LEARNING OUTCOME: To understand how knowledge, attitudes andpersonal health care practices affect health care professionals’ (HCPs’)patient care practices regarding weight management.

TEXT: A mail survey was sent to a stratified random sample of full timefaculty appointments of the University of Medicine and Dentistry of NewJersey during the academic year 2004, for the purposes of assessing theirknowledge, attitudes, personal health care and patient care practicesregarding weight management. Three-hundred and eighty nine of the 778surveys were returned (50% response rate). Descriptive statistics wereused to summarize data for all variables. Significance was set at alpha�.05. Pearson product moment correlation coefficient was used to comparerelationships among variables; one-way ANOVA was conducted to comparemean scores among various professions. More than 75% of faculty couldn’tidentify the clinical definition of obesity based on BMI, and 25 % didn’tknow the association between high waist circumference and increaseddisease risk. Reasons for not providing weight management care wererelated to it being “not their responsibility” or “outside of their specialty.”Significant correlations were found among faculty members’ knowledge(p�.01), attitudes (p�.03) personal health care (p�.01) and patient carepractices. No significant differences were found in mean scores forknowledge (p�.12), attitudes (p�.19), or personal health care practices(p�.93) among the various professions. Dentists had significantly lowerpatient care practice scores compared with physicians (p�.02) and nursingprofessionals (p�.03). Higher knowledge, positive attitudes and betterpersonal health care practices were associated with better adherence toevidenced-based patient care practices for weight management. Educationto improve HCPs’ use of screening techniques and need to take individualresponsibility for weight management is paramount.

FUNDING DISCLOSURE: None

TITLE: LIPID LOWERING FROM ISOFLAVONE EXTRACT AND SOYPROTEIN POWDER

AUTHOR(S): M.Z.Vitolins, DrPH, RD; H. Chen, PhD; G.L. Burke, MD,MSc; Wake Forest University School of Medicine, Winston-Salem, NC

LEARNING OUTCOME: To understand the effect that soy protein andisoflavone (soy) pills have on blood isoflavone levels and lipids ofmoderately hypercholesterolemic adults.

TEXT: The Food and Drug Administration approved a cardiovasculardisease health claim for foods containing soy protein. Little data existsregarding the effect of isoflavone pills on lipids. We evaluated the efficacyof isoflavone pills compared to soy protein for improving lipids in 51moderately hypercholesterolemic participants. This was a randomizeddouble-blind placebo controlled trial employing a 10-week cross-overdesign. The isocaloric treatments groups were: 1) Control (casein powder)plus placebo pills; 2) Casein powder plus 100 mg isoflavone pills; 3) Soypowder containing 100 mg isoflavones plus placebo pills. Thirty-sixCaucasian females, 4 African American females, and 11 Caucasian malesparticipated; median age was 56. Linear mixed effect models were used toassess differences between treatment groups in isoflavone and lipid levels.Pairwise comparisons were used to assess the differences in blood lipidsand isoflavones among treatment conditions. The mean mg/dl totalcholesterol for the control, soy powder, soy pill treatments were225.76�5.03, 237.38�5.03, and 226.92�4.87, respectively (P � 0.21).Serum isoflavone levels during soy powder treatment were significantlyhigher than during soy pill and control treatments (P�0.0001). Ourfindings illustrate that neither treatment improved lipids; however, serumisoflavone levels were higher after soy powder treatment. Isoflavone pillsare purchased for their cardiovascular disease prevention attributesdespite the lack of studies supporting their efficacy. To increase serumisoflavone levels, based on our study data, consumers should purchase soyfoods as they contain beneficial nutrients such as protein, calcium andfiber in addition to the isoflavones.

FUNDING DISCLOSURE: Funded Association of Teachers ofPreventive Medicine and the Centers for Disease Prevention and Control(GTS 10423) and the General Clinical Research Center (M01-RR07122).Protein supplements and pills provided by CentralSoya and CognisNutrition & Health.

TITLE: PREVENTION AND TREATMENT OF ARTHRITIS: THESOUTH CAROLINA PLAN FOR NUTRITION AND COMPLEMENTARYCARE

AUTHOR(S): P.G. Wolman, J.D. Smith, L.B. Phillian, J.S. Lewis, A.C.Turner; Department of Human Nutrition, Winthrop University, Rock Hill,SC 29733

LEARNING OUTCOME: To identify safe and effective preventive andtreatment strategies for rheumatoid arthritis and osteoarthritis for use innutrition and complementary care settings.

TEXT: Arthritis sufferers need help in finding safe and effective strategiesto cope with their disease. Food supplements, special diets, andcomplementary and alternative treatments for rheumatoid arthritis (RA)and osteoarthritis (OA) are touted in the popular press and available over-the-counter in pharmacies and grocery stores. The mainstay of nutritiontherapy for OA remains weight management and exercise; however,supplementation with glucosamine and chondroitin may decrease pain andreduce swelling. S-adenosylmethionine (SAMe); ginger (Zingiberofficinale); gamma-linolenic acid (evening primrose oil, borage seed oil,black current oil); devil’s claw root (Harpagophytum procumbens); as wellas vitamins A; riboflavin; pyridoxine; C and E; and selenium show promisefor OA treatment, as well. In rheumatoid arthritis food allergies,especially to animal products, have been associated with joint pain andswelling in conjunction with such allergic disorders as hay fever, asthma,and rhinitis. Whole food vegan diets may result in decreased inflammatoryresponse in allergic clients. The Mediterranean diet; increased omega-3fatty acid fish or capsules; olive oil; cruciferous vegetables; andB-crytoxanthin; as well as supplementation with pyridoxine and zinc havebeen shown to improve composite disease index scores and/or physicalfunction. In laboratory animals polyphenolic compounds in green tea havebeen effective in reducing the incidence and severity of arthritis. Fastingfor 7–10 days has been used as a prelude to an elimination diet; shortterm fasting results in relief of symptoms for RA clients. Safe nutritionaland complementary practices for relief of inflammation and symptoms inRA and OA are reviewed and assessed.

FUNDING DISCLOSURE: None

TITLE: STANDARDIZED PROTOCOL FOR USING INTRADIALYTICPARENTERAL NUTRITION (IDPN) AS AN ADJUNCT THERAPY INSEVERELY MALNOURISHED HEMODIALYSIS PATIENTS

AUTHOR(S): D.S. Baker, RD; J.L. Weinstein, MS, MBA, RD; D.K.Murray, MD; J.E. Parker, MD; K.J. Kerr, PharmD; P.J. Petnicki, MS, RD,FADA; United States Air Force, David Grant Medical Center, NutritionalMedicine, Travis AFB, CA

LEARNING OUTCOME: To develop and utilize a protocol for theinitiation, monitoring, and termination of Intradialytic ParenteralNutrition in maintenance hemodialysis patients.

TEXT: Patients receiving maintenance hemodialysis (MHD) often becomemalnourished as a result of inadequate dietary intake, loss of nutrientsinto the dialysate, abnormal metabolism, and co-morbid conditions, whichmay contribute to an increase in morbidity and morality. Protein energymalnutrition has been identified in up to 50% of patients receivinghemodialysis. Intradialytic Parenteral Nutrition (IDPN) has been used inour facility, a medium-sized military medical treatment center, as asupportive therapy in MHD patients unable to meet total nutritionrequirements orally. Several protocols on the use of IDPN have beensuggested, but none have yet been widely accepted/implemented. Afterreviewing available literature on IDPN, the hospital Nutrition SupportTeam developed a protocol with input from pharmacy, nephrology,endocrinology, general surgery, and nutritional medicine, to serve as aguideline for initiating, monitoring, and terminating IDPN. Key aspects ofthe protocol include: a defined treatment period (3–6 months in length),monitored nutrition outcomes, and trend analysis of complications andcomorbid conditions. Preliminary data suggest the protocol is easy to use,has standardized the IDPN ordering process among providers, andprovides an easy to use patient outcomes tracking tool. Our aim is tostandardize the use of IDPN among all providers within this facility inorder to improve efficacy and enable better outcomes monitoring. IDPNshows much promise as a clinically effective therapy for improving thenutritional status of malnourished patients receiving MHD. It isimperative that a standardized protocol is used to ensure maximumpatient safety and treatment effectiveness.

FUNDING DISCLOSURE: None

SUNDAY, OCTOBER 23

POSTER SESSION: NUTRITION ASSESSMENT/MEDICAL NUTRITION THERAPY

A-32 / August 2005 Suppl 2—Abstracts Volume 105 Number 8